Industry
InVivo Therapeutics
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 100/100
Failure Rate
100.0%
3 terminated/withdrawn out of 3 trials
Success Rate
0.0%
-86.6% vs industry average
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
1 of 0 completed trials have results
Key Signals
1 with results
Enrollment reporting
Analytics
N/A
3(100.0%)
3Total
N/A(3)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (3)
Showing 3 of 3 trials
NCT02138110Not ApplicableTerminated
The INSPIRE Study: Probable Benefit of the Neuro-Spinal Scaffold for Treatment of AIS A Thoracic Acute Spinal Cord Injury
Role: lead
NCT03762655Not ApplicableTerminated
Study of Probable Benefit of the Neuro-Spinal Scaffold™ in Subjects With Complete Thoracic AIS A Spinal Cord Injury as Compared to Standard of Care
Role: lead
NCT03105882Not ApplicableWithdrawn
Pilot Study of the Neuro-Spinal Scaffold for the Treatment of AIS A Cervical Acute SCI
Role: lead
All 3 trials loaded